NIH-funded research R01 grant

Exploring new signaling molecules for cardiovascular health

Official title: Nitro-nitrate fatty acid derivatives as novel cGMP-dependent and cGMP-independent signaling mediators

Funded at University of Pittsburgh at Pittsburgh · NIH-11001144 · Data updated 2026-11-12

This study is looking at how certain compounds from our diet might help improve heart health by affecting inflammation and gene activity, with the hope of finding new treatment options for people with heart conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2026
Funding year2025
Award (this year)$540,936
NIH project number5R01HL162787-03
Project IDNIH-11001144 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for cardiovascular diseases or those currently managing such conditions.

Less likely to help

Patients with non-cardiovascular related health issues may not receive any benefit from this research.

What this research studies

This research investigates the potential of nitro-nitrate fatty acid derivatives as new signaling mediators that could improve cardiovascular health. It focuses on how these compounds, derived from dietary sources, can influence biological processes related to cardiovascular diseases. By examining their effects on gene expression and inflammation, the study aims to identify alternative therapies that could enhance treatment outcomes for patients with cardiovascular conditions.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that improve cardiovascular health and reduce the incidence of related diseases.

How similar studies have gone: Previous research has shown promising results with dietary interventions in cardiovascular health, suggesting that this approach may yield beneficial outcomes.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Fazzari, Marco — University of Pittsburgh at Pittsburgh
  • Study coordinator: Fazzari, Marco

Related research

Other NIH-funded projects on the same topics.

  • Elastomeric membranes for safer pelvic organ prolapse repair

    A new 3D-printed elastomeric membrane made from polycarbonate urethane is being tested to replace stiff polypropylene meshes for pelvic organ prolapse in women, aiming to reduce complications.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11668074

  • Role of hyaluronan in egg development and ovarian reserve

    This grant studies how the hyaluronan matrix in the ovary affects the aging of the female reproductive system and the pool of eggs available.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11668041

  • Regulatory switches that control imprinting in early human development

    This grant studies how certain genes stay “one-copy” active in early development and what goes wrong in assisted reproduction, with a focus on imprinting disorders.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11668004

  • Identifying molecular signs of imprinting errors linked to fertility treatments

    This grant studies how assisted reproductive technologies may cause imprinting errors in embryos and how these errors relate to certain birth conditions, with implications for families using infertility treatments.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11667742

  • Bioadhesive vaginal film for 7-day protection against HIV, HSV, and pregnancy

    A vaginal film that slowly releases antibodies to prevent HIV, HSV, and unintended pregnancy for about a week from a single use.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11645331

  • Spermatogonial stem cell transplantation and culture in patients

    Researchers are testing a way to transplant or grow sperm-producing cells back in boys and men who stored tissue before cancer treatment, to help them have biological children in the future.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11645297

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.